Pharmaceutical Industry Today

Computational Biology Market to Growing Dependence and Popularity

A latest market report published by Transparency Market Research is Computational Biology Market to Growing Dependence and Popularity
Published 10 March 2016
Transparency Market Research’s new market report, titled ‘Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018’, provides a comprehensive analysis of the computational biology market on the basis of application, tools, and services.This report studies the global computational biology market for  through the perspective of disease modeling and cellular modeling. It shows how computers are widely being used for examining the mechanism and various processes of cell biology. Computational biology is a field of science that is critically used in the healthcare industry. Many biotechnology and pharmaceutical companies use computational biology to reduce the incidence of late stage failures of drugs and curb the research and development costs. 

Get Free Sample Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1120

The computational biology market deals with the use of biology and computers for drug discovery and drug development. This is conducted through modeling and simulation models for pharmacokinetics and pharmacodynamics. Rise in late stage drug failure coupled with contraction of innovative drugs has led to huge financial losses to the biotech pharmaceutical companies. It has therefore become imperative for pharmaceutical companies to invest in computational biology. In 2011, the global computational biology market was valued to be USD 760.2 million and is expected to grow at a CAGR of 21.3% from 2012 to 2018. 

Computational biology also helps to reduce extensive use of humans in trials and is therefore useful for pediatric trials, trials on pregnant women and orphan disease research. The drug discovery market accounts to be the largest market for computational biology as its use at this stage helps in reduction of drug failure in the subsequent phase i.e. development phase. Currently, there is a large market of contract service providers of computational biology; nonetheless multinational pharmaceutical companies are setting up their own computational biology centers to fasten the process of drug discovery and development. Governments across the globe are funding infrastructure and academic courses to improve and increase the number of computational biologists. 

Large pharmaceutical companies such as Pfizer, Roche, Novartis, and Sanofi are now exploring this market to have better outcomes of clinical trials. The drugs which have failed in the last stage of clinical trials are also being studied using computational biology to understand and apply its use for other disease indications. Though North America remains the largest market in the world, Asian countries namely India and China are witnessing fast growth and are predicted to emerge as dominating markets in the near future. The major players of this market are Schrödinger, Accelrys, Compugen, Entelos, Rhenovia Pharma and others.

Other Industry News

Ready to start publishing

Sign Up today!